ST. LOUIS (KMOX) - A Japanese pharmaceutical company thinks there's promising work in a St. Louis startup that's working on a way to turn the body's immune system against cancer.
How promising? The publicly traded Oncolys BioPharma is investing $3.3 million into a St. Louis firm called Unleash Immuno Oncolytics...